Neonc Technologies (NASDAQ:NTHI) Stock: Insider Amir Heshmatpour Buys 50,000 Shares

Neonc Technologies Holdings, Inc. (NASDAQ:NTHI) CEO Amir Heshmatpour purchased 50,000 shares of Neonc Technologies stock in a transaction dated Tuesday, November 10th. The shares were bought at an average price of $4.19 per share, with a total value of $209,500.00. Following the completion of the transaction, the chief executive officer owned 3,313,000 shares in the company, valued at approximately $13,881,470. This trade represents a 1.53% increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.

Neonc Technologies Price Performance

Shares of NTHI stock opened at $4.52 on Thursday. The firm has a 50-day moving average price of $3.30 and a 200 day moving average price of $5.31. Neonc Technologies Holdings, Inc. has a twelve month low of $2.50 and a twelve month high of $12.00.

Neonc Technologies (NASDAQ:NTHI) last posted its earnings results on Thursday, November 5th. The company reported ($0.28) earnings per share for the quarter, missing the consensus estimate of ($0.25) by ($0.03).

Analysts Set New Price Targets

Several research analysts have commented on the stock. Roth Capital assumed coverage on shares of Neonc Technologies in a research report on Thursday, September 24th. They issued a “buy” rating for the company. Weiss Ratings downgraded Neonc Technologies from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday, October 21st. Wall Street Zen raised Neonc Technologies from a “sell” rating to a “hold” rating in a report on Saturday, November 7th. BTIG Research reaffirmed a “buy” rating and issued a $15.00 price objective on shares of Neonc Technologies in a report on Tuesday, September 8th. Finally, Zacks Research upgraded Neonc Technologies from a “strong sell” rating to a “hold” rating in a research report on Thursday, November 5th. Four investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $16.00.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the stock. Bank of America Corp DE purchased a new position in shares of Neonc Technologies during the 2nd quarter valued at $1,017,000. BlackRock Inc. purchased a new stake in shares of Neonc Technologies during the second quarter worth $815,000. Westmount Partners LLC raised its holdings in shares of Neonc Technologies by 355.2% during the second quarter. Westmount Partners LLC now owns 197,178 shares of the company’s stock worth $893,000 after acquiring an additional 153,858 shares in the last quarter. Finally, Global Retirement Partners LLC acquired a new stake in Neonc Technologies during the second quarter valued at $126,000.

About Neonc Technologies

NeOnc Technologies Holdings, Inc. is a biotechnology company developing treatments for brain tumors and other central nervous system cancers. Its research focuses on approaches intended to deliver therapies to the brain, where the blood-brain barrier can limit the effectiveness of conventional treatments. The company’s pipeline includes NEO100, a formulation of perillyl alcohol designed for intranasal delivery, and NEO212, a compound combining perillyl alcohol with temozolomide. These candidates are being developed for potential use in brain cancer treatment.